Extrinsic coagulation pathway inhibitor and heparin cofactor II during normal and hypertensive pregnancy.
Sandset
P M
PM
Department of Medicine, Aker University Hospital, Oslo, Norway.
Hellgren
M
M
Uvebrandt
M
M
Bergström
H
H
D000328:Adult; D005167:Factor VII / Q000032:analysis* / Q000037:antagonists & inhibitors; D005260:Female; D005865:Gestational Age; D015844:Heparin Cofactor II / Q000032:analysis*; D006801:Humans; D006973:Hypertension / Q000097:blood*; D008074:Lipoproteins / Q000032:analysis*; D011225:Pre-Eclampsia / Q000097:blood; D011247:Pregnancy / Q000097:blood*; D011249:Pregnancy Complications, Cardiovascular / Q000097:blood*; D013925:Thromboplastin / Q000032:analysis* / Q000037:antagonists & inhibitors
D008074:Lipoproteins; C051928:lipoprotein-associated coagulation inhibitor; D015844:Heparin Cofactor II; D005167:Factor VII; D013925:Thromboplastin